Small
Cell Lung Cancer Therapeutics Market - Global Industry Insights, Trends,
Outlook, and Opportunity Analysis, 2018-2026
Small Cell Lung Cancer (SCLC) is
malignant form of cancer arising within the lungs. SCLC is characterized by
high growth rate, shorter doubling time than the non-small cell lung tumors.
SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is
highly associated with tobacco, unhealthy food, alcohol, HIV infected, chronic
infections or related family history, and physical inactivity. The decrease in
smoking is reflected as the substantial decrease in the incidence of SCLC. The
symptoms include dyspnea, blood in sputum, weight loss, cough, and debility.
Global rise in number of cancer
cases expected to support the growth of small cell lung cancer therapeutics
market in the near future
According to the American Cancer
Society Statistics in 2016, maximum cases of SCLC occur in individuals aged
60-80 years with an estimated global death rate being 30,000 per year. Also,
according to the World Health Organization (WHO), lung cancer is the second
most prevailing cancer in men and women causing 1.59 million deaths in 2012.
The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launch
of innovative radiation therapies, and premium priced drugs are the major
factors driving the growth of lung cancer therapeutics market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/799
Additionally, rising demand for
targeted therapies and platinum-based chemotherapies is likely to have an optimistic
impact on the small lung cancer therapeutics market in the forecast period.
Also, increasing diagnostic facilities by the government, provision of
guidelines to cancer patients by International Healthcare Organizations are the
major factors contributing to the rising of small cell lung cancer market.
However, expensive treatments, lack of awareness leading to late diagnosis are
the major factors restraining the small cell lung cancer market growth.
Enhanced health care dynamics to
boost the Asia Pacific small cell lung cancer market
Regional segmentation of small
cell lung cancer therapeutics market by Coherent Market Insights comprises of
North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
According to the American Cancer Society Statistics in 2017, around 222,500
cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510
in women, where small cell lung cancer accounts for 15 percent of lung cancers
in the U.S. North America is expected to dominate the market owing to the high
developed regions, improved healthcare setup, and growing awareness about
healthcare. Asia Pacific is expected to drive the growth of SCLC market in the
forecast period owing to the growing awareness of health care, government
funding, and the presence of medical requirements for cancer therapeutics in
the emerging economies such as India and China.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/small-cell-lung-cancer-therapeutics-market-799
Key players in the Small Cell Lung
Cancer Therapeutics Market
Key players operating the small
cell lung cancer therapeutics market include Bristol-Myers Squibb,
GlaxoSmithKline, Menarini, Sanofi, and ZIOPHARM Oncology.
Platinum derivatives segment
accounts for highest revenue share owing to the higher metastasis control rate
The global small cell lung cancer
therapeutics market is segmented on the basis of drug therapy, and distribution
channel.
On the basis of drug therapy, the
global small cell lung cancer therapeutics market is segmented into:
Targeted Therapy Drugs
Immunotherapy Drugs
Platinum Derivatives
On the basis of distribution
channel, the global small cell lung cancer therapeutics market is segmented
into:
Hospital Pharmacies
Retail and Online Pharmacies
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/799
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment